List view / Grid view
20 November 2015 | By Victoria White
The technology has already been successfully tested in the laboratory. If it works in patients, the therapy could one day revolutionise treatment for many forms of cancer...
30 October 2015 | By Victoria White
MD Anderson's Moon Shots Programme is an unprecedented effort and novel organisational model designed to more rapidly convert scientific discoveries into life-saving advances...
13 October 2015 | By Victoria White
ImaginAb will conduct preclinical research using its immune imaging agent, IAB22M2C, to detect T-cell trafficking, redirection and infiltration in response to Lilly oncology molecules...
25 September 2015 | By Victoria White
TLR agonists are promising agents that activate innate immune cells and enhance the visibility of cancer tumours...
10 September 2015 | By Victoria White
The SAS1B protein appears only on egg cells and cancer cells, and could serve as a target for tiny tracking probes created using monoclonal antibodies...
4 September 2015 | By Victoria White
Researchers have shown that combining immunotherapy with aspirin or other COX inhibitors substantially slowed bowel and melanoma skin cancer growth in mice...
6 August 2015 | By Victoria White
Researchers from the University of Pennsylvania have identified a major genetic factor that keeps moles in their usual non-cancerous, no-growth state...
29 June 2015 | By Victoria White
Immunocore and Lilly have entered into a collaboration to explore the utility of IMCgp100 in combination with galunisertib and merestinib in melanoma...
26 June 2015 | By Victoria White
Siemens and BioNTech will work together on the construction of a fully automated and digitalised production site for BioNTech's personalised cancer vaccines...
24 June 2015 | By Victoria White
Novogen has announced that its candidate cytotoxic chemotherapy drug, Anisina, has proved an effective anti-cancer agent in animals...
18 June 2015 | By Victoria White
Melanoma patients with high levels of a protein that controls the expression of pro-growth genes are less likely to survive, according to a new study...
14 May 2015 | By Victoria White
Novogen has confirmed that drug candidate, Anisina, is an effective monotherapy against human melanoma in an animal model...
12 May 2015 | By Victoria White
Mainz-based researchers have made significant advances with regard to the development of individualised cancer immunotherapy strategies...
11 May 2015 | By Victoria White
Novogen, in conjunction with Australian paediatric cancer researchers, released key preclinical data on experimental cancer drug-candidate, TRXE-009...
7 May 2015 | By Victoria White
Plexxikon and MSD have announced a collaborative clinical trial that will evaluate the combination of PLX3397 and KEYTRUDA in melanoma...
